← Leaderboards
Elizabeth M Byrnes
Tufts University Boston
$8,518,964
Attributed
$12,981,305
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $7.2M · FY2009–25$10M$7.5M$5M$2.5M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,981,305 · 7
By mechanism
UG3$6,693,512 · 1
R01$5,317,293 · 2
R21$647,000 · 2
R03$323,500 · 2
Top collaborators
- Emmanuel N Pothos1 shared
- Barbara Lee Waszczak1 shared
Most similar at Tufts University Boston
Same institution · by research overlap
- Fair M Vassoler$861,299
- Emmanuel N Pothos$3,934,353
Others in their field
Top investigators on “Rattus”
- Barney Sparrow · Battelle Memorial Institute$76,162,078
- Reshan Fernando · Research Triangle Institute$42,714,061
- Boris Tabakoff · University Of Colorado Denver$35,561,072
- Yasmin L Hurd · Icahn School Of Medicine At Mount Sinai$35,063,410
- Milton D Hejtmancik · Battelle Centers/Pub Hlth Res & Evaluatn$34,625,987
- John Damon Chodera · Sloan-Kettering Inst Can Research$33,543,727
Research focus
RattusFemaleModificationAnimal ModelPharmaceutical PreparationsSelf AdministrationOffspringSubstance Abuse ProblemAdolescenceAdult ChildrenBasePatternAnimalsReproductiveOpioidSubstance Use DisorderOxycodoneRewardsStressOpioid AbuseMaleAdultMorphineIntergenerational
Grant awards (24)
Fentanyl Overdose, Anhedonia and Relapse Risk$193,250
R21 · FY2025 · DA · contact PI
Oxycodone, Neonatal Opioid Withdrawal Syndrome, and Adult Abuse Liability$464,257
R01 · FY2024 · DA · contact PI
Oxycodone, Neonatal Opioid Withdrawal Syndrome, and Adult Abuse Liability$86,870
R01 · FY2024 · DA · contact PI
Oxycodone, Neonatal Opioid Withdrawal Syndrome, and Adult Abuse Liability$464,257
R01 · FY2023 · DA · contact PI
Oxycodone Neonatal Opioid Withdrawal Syndrome and Adult Abuse Liability$86,870
R01 · FY2023 · DA · contact PI
Oxycodone, Neonatal Opioid Withdrawal Syndrome, and Adult Abuse Liability$464,257
R01 · FY2022 · DA · contact PI
An Intranasal GDNF Gene Therapy for Opioid Relapse Reduction$6,693,512
UG3 · FY2021 · DA
Oxycodone, Neonatal Opioid Withdrawal Syndrome, and Adult Abuse Liability$464,257
R01 · FY2021 · DA · contact PI
Oxycodone, Neonatal Opioid Withdrawal Syndrome, and Adult Abuse Liability$487,657
R01 · FY2020 · DA · contact PI
Relaxin 3 and sex differences in post-stroke depression$206,250
R21 · FY2018 · NS · contact PI
Maternally Transmitted Opiate Abuse Vulnerability$371,250
R01 · FY2017 · DA · contact PI
Relaxin 3 and sex differences in post-stroke depression$247,500
R21 · FY2017 · NS · contact PI
Maternally Transmitted Opiate Abuse Vulnerability$367,537
R01 · FY2016 · DA · contact PI
Maternally Transmitted Opiate Abuse Vulnerability$365,681
R01 · FY2015 · DA · contact PI
Sex Differences in Adolescent Exposure to Morphine on Reward Related Behaviors in Subsequent Offspring$100,000
R01 · FY2015 · DA · contact PI
Maternally Transmitted Opiate Abuse Vulnerability$371,250
R01 · FY2014 · DA · contact PI
Embryo Transfer for the Study of Transgenerational Modifications in Morphine Sens$82,500
R03 · FY2014 · DA · contact PI
Maternally Transmitted Opiate Abuse Vulnerability$371,250
R01 · FY2013 · DA · contact PI
Embryo Transfer for the Study of Transgenerational Modifications in Morphine Sens$82,500
R03 · FY2013 · DA · contact PI
Maternally Transmitted Opiate Abuse Vulnerability$277,287
R01 · FY2011 · DA · contact PI
Maternally Transmitted Opiate Abuse Vulnerability$285,863
R01 · FY2010 · DA · contact PI
Maternally Transmitted Opiate Abuse Vulnerability$288,750
R01 · FY2009 · DA · contact PI
Reproductive Consequences of Pubertal Morphine Abuse$79,250
R03 · FY2002 · DA
Reproductive Consequences of Pubertal Morphine Abuse$79,250
R03 · FY2001 · DA